• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-氨基-3-(4-氯苯甲酰基)-4-[(4-芳基哌嗪-1-基)甲基]-5-取代噻吩的合成与生物评价。5-取代基对 A1 腺苷受体变构增强剂活性的影响。

Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.

机构信息

Dipartimento di Scienze Chimiche e Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44121, Ferrara, Italy.

出版信息

J Med Chem. 2012 Sep 13;55(17):7719-35. doi: 10.1021/jm3007504. Epub 2012 Aug 28.

DOI:10.1021/jm3007504
PMID:22889387
Abstract

We have recently reported a detailed structure-activity relationship study around a wide series of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]thiophene derivatives as potent allosteric enhancers of the A(1) adenosine receptor. In the current study, we have continued to explore the potential of these molecules by synthesizing of a novel series of analogues that share a common 2-amino-3-(4-chlorobenzoyl)thiophene nucleus. Modifications were focused on varying the nature and the position of electron-withdrawing or electron-releasing groups on the phenyl of an arylpiperazine moiety attached at the 4-position of the thiophene ring by a methylene chain, combined with the presence of small alkyl groups (methyl or ethyl), bromine, or aryl moieties at the thiophene C-5 position. In this series of compounds, substitution at the 5-position had a fundamental effect on activity, with the 5-aryl group contributing additively to the allosteric enhancer activity. The thiophene C-5 aryl derivatives 4ad, 4ak, and 4al were the most active compounds in binding and functional experiments.

摘要

我们最近报道了一项围绕广泛的 2-氨基-3-(4-氯苯甲酰基)-4-[(4-芳基哌嗪-1-基)甲基]噻吩衍生物的详细结构-活性关系研究,这些衍生物是有效的 A(1)腺苷受体变构增强剂。在当前的研究中,我们通过合成一系列共享共同的 2-氨基-3-(4-氯苯甲酰基)噻吩核的新型类似物,继续探索这些分子的潜力。修饰集中在通过亚甲基链连接到噻吩环 4-位的芳基哌嗪部分的苯环上改变吸电子或供电子基团的性质和位置,同时在噻吩 C-5 位置存在小烷基(甲基或乙基)、溴或芳基部分。在这一系列化合物中,5-位的取代对活性有根本影响,5-芳基基团对变构增强剂活性有附加贡献。噻吩 C-5 芳基衍生物 4ad、4ak 和 4al 在结合和功能实验中是最活跃的化合物。

相似文献

1
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.2-氨基-3-(4-氯苯甲酰基)-4-[(4-芳基哌嗪-1-基)甲基]-5-取代噻吩的合成与生物评价。5-取代基对 A1 腺苷受体变构增强剂活性的影响。
J Med Chem. 2012 Sep 13;55(17):7719-35. doi: 10.1021/jm3007504. Epub 2012 Aug 28.
2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.2-氨基-3-芳酰基-4-[(4-芳基哌嗪-1-基)甲基]噻吩的构效关系。第 2 部分:研究芳基哌嗪部分的苯基上不同取代基对 A₁ 腺苷受体变构增强活性的影响。
Bioorg Med Chem. 2012 Jan 15;20(2):996-1007. doi: 10.1016/j.bmc.2011.11.044. Epub 2011 Dec 1.
3
Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.新型 2-氨基-3-(4-氯苯甲酰基)-4-取代噻吩作为 A1 腺苷受体变构增强剂的合成及生物学效应。
Eur J Med Chem. 2013 Sep;67:409-27. doi: 10.1016/j.ejmech.2013.07.002. Epub 2013 Jul 13.
4
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.2-氨基-3-(4-氯苯甲酰基)-4-[N-(取代)哌嗪-1-基]噻吩作为A1腺苷受体有效变构增强剂的合成及生物学评价
J Med Chem. 2008 Sep 25;51(18):5875-9. doi: 10.1021/jm800586p. Epub 2008 Aug 26.
5
Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.新型2-氨基-3-芳酰基噻吩衍生物作为A1腺苷受体激动剂变构调节剂的合成与生物学评价。位置依赖性效应研究。
Eur J Med Chem. 2015 Aug 28;101:185-204. doi: 10.1016/j.ejmech.2015.06.041. Epub 2015 Jun 24.
6
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.基于2-氨基-3-(4'-氯苯甲酰基)-4-取代-5-芳乙炔基噻吩的新型A1腺苷受体变构增强剂的合成及生物学评价
J Med Chem. 2014 Sep 25;57(18):7673-86. doi: 10.1021/jm5008853. Epub 2014 Sep 12.
7
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.新型2-氨基-3-芳酰基-4-新戊基-5-取代噻吩衍生物作为A₁腺苷受体变构增强剂的合成及生物学评价
Bioorg Med Chem. 2014 Jan 1;22(1):148-66. doi: 10.1016/j.bmc.2013.11.043. Epub 2013 Dec 1.
8
Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptor.2-氨基-3-杂芳酰基噻吩的合成及其作为人A1受体潜在变构增强剂的活性评估。
Eur J Med Chem. 2004 Oct;39(10):855-65. doi: 10.1016/j.ejmech.2004.06.009.
9
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.新型2-氨基-3-萘甲酰基噻吩作为A1腺苷受体变构增强剂的合成及生物学效应
J Med Chem. 2003 Feb 27;46(5):794-809. doi: 10.1021/jm0210212.
10
The synthesis and biological evaluation of 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophenes as allosteric modulators of the A1 adenosine receptor.2-氨基-4,5,6,7,8,9-六氢环辛[b]噻吩作为 A1 腺苷受体别构调节剂的合成与生物评价。
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3704-7. doi: 10.1016/j.bmcl.2011.04.080. Epub 2011 May 4.

引用本文的文献

1
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A Adenosine Receptor Positive Allosteric Modulators.2-氨基-5-芳基乙炔基-噻吩-3-基-(苯基)甲酮作为A腺苷受体正向变构调节剂
ACS Med Chem Lett. 2023 Nov 13;14(12):1640-1646. doi: 10.1021/acsmedchemlett.3c00315. eCollection 2023 Dec 14.
2
Adenosine Receptors as Potential Therapeutic Analgesic Targets.腺苷受体作为潜在的治疗性镇痛靶点。
Int J Mol Sci. 2023 Aug 24;24(17):13160. doi: 10.3390/ijms241713160.
3
Small molecule allosteric modulation of the adenosine A receptor.
小分子变构调节腺苷 A 受体。
Front Endocrinol (Lausanne). 2023 Jun 26;14:1184360. doi: 10.3389/fendo.2023.1184360. eCollection 2023.
4
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications.腺苷受体变构调节剂的最新进展及其治疗应用
Front Pharmacol. 2022 Oct 5;13:1030895. doi: 10.3389/fphar.2022.1030895. eCollection 2022.
5
A Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?A 型腺苷受体部分激动剂和变构调节剂:向临床迈进?
Front Pharmacol. 2020 Dec 9;11:625134. doi: 10.3389/fphar.2020.625134. eCollection 2020.
6
Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.靶向腺苷受体:急性和慢性疼痛的潜在药理学途径。
Int J Mol Sci. 2020 Nov 18;21(22):8710. doi: 10.3390/ijms21228710.
7
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through AAR Positive Allosteric Modulation.通过嘌呤受体 A1(AAR)正向变构调节,可将腺苷对 PC12 细胞谷氨酸诱导的细胞毒性的有害作用转移到神经保护作用。
Cells. 2020 May 18;9(5):1242. doi: 10.3390/cells9051242.
8
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.变构调节 A 类 G 蛋白偶联受体:靶点、药物及新的概念。
J Med Chem. 2019 Jan 10;62(1):88-127. doi: 10.1021/acs.jmedchem.8b00875. Epub 2018 Aug 28.
9
The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers.腺苷 A1 受体的第二个细胞外环介导变构增强剂的活性。
Mol Pharmacol. 2014 Feb;85(2):301-9. doi: 10.1124/mol.113.088682. Epub 2013 Nov 11.